Filing Flows › Mimedx Group (MDXG) › Wound revenue
Mimedx Group (MDXG) Wound revenue by quarter
Mimedx Group's Wound revenue was $22.3M in Q3 2026 (third quarter 2026), -11% from Q2 2026. Over the last 7 quarters it ranged from $22.3M (Q3 2026) to $78.7M (Q4 2025).
| Quarter | Wound revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $22.3M | -11% | -71% |
| Q2 2026 | $25.1M | +11% | -61% |
| Q1 2026 | $22.6M | -71% | -60% |
| Q4 2025 | $78.7M | +2% | — |
| Q3 2025 | $77.1M | +20% | — |
| Q2 2025 | $64.5M | +15% | — |
| Q1 2025 | $56.1M | — | — |
Q3 2026 at a glance
Mimedx Group, Q3 2026: revenue $62.3M (-45% year over year), operating margin -18.8%, net loss $8.7M, operating cash flow $3.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Mimedx Group's Wound revenue?
Mimedx Group's Wound revenue was $22.3M in Q3 2026 (third quarter 2026), -11% from Q2 2026.
How has Mimedx Group's Wound revenue changed?
Over the last 7 quarters it ranged from $22.3M (Q3 2026) to $78.7M (Q4 2025).